Medical device company Integra LifeSciences (NASDAQ:IART) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.4% year on year to $391.9 million. Revenue guidance for the full year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results